sarclisa isatuximab 100 mg/5 ml concentrated injection vial
sanofi-aventis australia pty ltd - isatuximab, quantity: 100 mg - injection, concentrated - excipient ingredients: histidine; histidine hydrochloride monohydrate; polysorbate 80; sucrose; water for injections - sarclisa is indicated:,? in combination with pomalidomide and dexamethasone, for the treatment of patients with multiple myeloma (mm) who have received at least two prior therapies including lenalidomide and a proteasome inhibitor (pi).,? in combination with carfilzomib and dexamethasone, for the treatment of patients with multiple myeloma who have received at least one prior therapy.
epilim 200 tablet 200 mg
sanofi-aventis singapore pte. ltd. - sodium valproate - enteric coated tablet - 200.00 mg - sodium valproate 200.00 mg
lantus optiset solution for injection 100 iu/ml
sanofi-aventis singapore pte. ltd. - insulin glargine - injection - 100 iu/ml
epilim® 400 mg powder for injection infusion
sanofi-aventis singapore pte. ltd. - sodium valproate - injection, powder, for solution - 400 mg/vial - sodium valproate 400 mg/vial
mucosolvan 24 hours capsule 75mg
opella healthcare singapore pte. ltd. - ambroxol hydrochloride - capsule, delayed release - 75mg - ambroxol hydrochloride 75mg
menactra® solution for injection
sanofi-aventis singapore pte. ltd. - diphtheria toxoid protein; meningococcal (serogroup a) polysaccharide (monovalent conjugate); meningococcal (serogroup c) polysaccharide (monovalent conjugate); meningococcal (serogroup w-135) polysaccharide (monovalent conjugate); meningococcal (serogroup y) polysaccharide (monovalent conjugate) - injection, solution - 48 microgram (diptheria toxoid quantity is approximate and dependent on the conjugate polysaccharide to protein ratio) - diphtheria toxoid protein 48 mcg/dose (0.5 ml) (diphtheria toxoid quantity is approximate and dependent on the conjugate polysaccharide to protein ratio); meningococcal (serogroup a) polysaccharide (monovalent conjugate) 4 mcg/dose (0.5 ml); meningococcal (serogroup c) polysaccharide (monovalent conjugate) 4 mcg/dose (0.5 ml); meningococcal (serogroup w-135) polysaccharide (monovalent conjugate) 4 mcg/dose (0.5 ml); meningococcal (serogroup y) polysaccharide (monovalent conjugate) 4 mcg/dose (0.5 ml)
apidra 100 units/ml solution for injection in cartridge
sanofi-aventis singapore pte. ltd. - insulin glulisine - injection, solution - 3.49 mg
lasix injection 20 mg/2 ml
sanofi-aventis singapore pte. ltd. - furosemide - injection - 20 mg/2 ml
tritace 10 tablet 10 mg
sanofi-aventis singapore pte. ltd. - ramipril - tablet - 10 mg
ticlid tablet 250 mg (film-coated)
sanofi-aventis singapore pte. ltd. - ticlopidine hcl - tablet, film coated - 250 mg